Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate is effective for rheumatoid arthritis but often causes side effects like nausea and liver issues.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Certain topical drugs can regrow hair in mice.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Ethosomes can effectively deliver drugs deep into the skin, improving treatment for various skin conditions.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Sulfasalazine might cause hair loss, especially in women, and stopping it can reverse the hair loss.